ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TELA vs DRIO // RETURN ON INVESTED CAPITAL (ROIC)

TELA Bio Inc. (NASDAQ) VS. DarioHealth Corp. (NASDAQ) • 15-METRIC TALLY: TELA 5 — DRIO 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TELA VS. DRIO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TELA DRIO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 67.70% 56.60% +11.10 TELA /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -42.00% -60.00% +18.00 TELA /operating-margins <GO>
Net Profit Margin -48.30% -60.00% +11.70 TELA /net-margins <GO>
Revenue Growth (YoY) 15.80% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 5/9 -1.00 DRIO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 37.6 27.3 +10.30 TELA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $36.6M $29.4M $7.2M TELA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TELA REV DRIO REV TELA GROSS % DRIO GROSS % TELA FCF DRIO FCF
FY 2025 $80.3M $22.4M 67.7% 56.6% -$28.7M -$26.1M
FY 2024 $69.3M $27.0M 67.1% 49.1% -$42.6M -$38.7M
FY 2023 $58.5M $157.3M — — -$40.9M -$30.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TELA // BETA —
DRIO // BETA —